Circulating [ftcn]    
MICRO RNA 122A [gngm]    
Diagnostic Marker [clna]    
HEPATOCELLULAR CARCINOMA [neop]    
Purpose [ftcn]    
Study [mnob]    
Evaluate [hlca]    
Value [qnco]    
Circulating [ftcn]    
miRNA 122A [gngm]    
miRNA 221 [gngm]    
DIAGNOSIS [fndg]    
HEPATOCELLULAR CARCINOMA [neop]    
Methods [inpr]    
Serum sample [bdsu]    
Obtained [ftcn]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
matched [resa]    
Sex [orgf]    
matched [resa]    
Healthy Volunteers [popg]    
Isolated [ftcn]    
Serum sample [bdsu]    
alpha fetoprotein levels [lbtr]    
miRNA 122A [gngm]    
miRNA 221 [gngm]    
Cases [ftcn]    
control [qlco]    
Quantify [qnco]    
SN [geoa]    
internal control [menp]    
Diagnostic [fndg]    
Value [qnco]    
miRNA 122A [gngm]    
miRNA 221 [gngm]    
Compared [acty]    
Receiver Operating Characteristic [qnco]    
SERUM [bdsu]    
miRNA 122A [gngm]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
Reduced [qlco]    
Comparison [acty]    
Healthy Control [qlco]    
Correlated [qlco]    
Known [qlco]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Circulating miRNA [nnon]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
Higher [qlco]    
Compared [acty]    
Control Group [grup]    
Not statistically significant [fndg]    
Receiver Operating Characteristic [qnco]    
Revealed [qlco]    
Diagnostic [fndg]    
POWER [hcpp]    
miRNA 122A [gngm]    
Suboptimal [qlco]    
Compared [acty]    
Serum alpha-fetoprotein [lbpr]    
Serum alpha-fetoprotein [lbpr]    
miRNA 122A [gngm]    
Combined [qlco]    
Performance [inbe]    
Alone [qnco]    
SERUM [bdsu]    
miRNA 122A [gngm]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
miRNA 122A [gngm]    
Diagnostic [fndg]    
Tool [mnob]    
HEPATOCELLULAR CARCINOMA [neop]    
SUPERIOR [spco]    
Needed [qlco]    
Evaluate [hlca]    
Diagnostic [fndg]    
POWER [hcpp]    
PLASMA [bdsu]    
miRNA 122A [gngm]    
HEPATOCELLULAR CARCINOMA [neop]    
